K. Maruyama

发表

Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats

T. Inoue, K. Akahane, A. Yokoyama, 2014, Drug Research.

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.

J. Kuroda, Y. Yamazaki, K. Maruyama, 2006, European journal of pharmacology.

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line

J. Kuroda, H. Kusama, Y. Yamazaki, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.

K. Nakao, K. Hosoda, H. Masuzaki, 2007, American journal of physiology. Endocrinology and metabolism.

Comparison of Phosphate Binding Capacities of PA21, A Novel Phosphate Binder, with those of other Phosphate Binders in vitro and in vivo

A. Yaguchi, K. Maruyama, M. Kobayashi, 2016, Drug Research.

Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats

K. Maruyama, S. Tatemichi, Mamoru Kobayashi, 2015, Pharmacology.

Ranolazine Attenuates Palmitoyl‐l‐carnitine‐induced Mechanical and Metabolic Derangement in the Isolated, Perfused Rat Heart

F. Ushikubi, Y. Abiko, A. Hara, 2000, The Journal of pharmacy and pharmacology.

Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: comparison with dichloroacetate.

Y. Abiko, H. Matsumura, A. Hara, 1998, Japanese journal of pharmacology.

Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts.

Y. Yamazaki, M. Kojima, K. Ojima, 2006, European journal of pharmacology.

Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats

K. Maruyama, S. Tatemichi, Mamoru Kobayashi, 2017, BMC Urology.

SALIVATION TRIGGERED BY PILOCARPINE INVOLVES AQUAPORIN‐5 IN NORMAL RATS BUT NOT IN IRRADIATED RATS

H. Kusama, K. Maruyama, T. Asari, 2009, Clinical and experimental pharmacology & physiology.

Effects of Pilocarpine Hydrochloride and Cevimeline on Submandibular/ Sublingual Salivation in Rat Xerostomia Model Produced by X-Ray Irradiation

H. Kusama, M. Kojima, K. Maruyama, 2003, Arzneimittelforschung.

Effects of ritobegron (KUC-7483), a novel β3-adrenoceptor agonist, on both rat bladder function following partial bladder outlet obstruction and on rat salivary secretion: a comparison with the effects of tolterodine.

H. Kusama, Y. Yamazaki, K. Maruyama, 2012, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

Silodosin, an α1A-Adrenoceptor Antagonist, May Ameliorate Ischemia-Induced Bladder Denervation and Detrusor Dysfunction by Improving Bladder Blood Flow

O. Yamaguchi, M. Nomiya, K. Maruyama, 2016, Pharmacology.

Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.

J. Kuroda, H. Kusama, K. Maruyama, 2012, Urology.

Ranolazine:an Antiischemic Drug with a Novel Mechanism of Action

F. Ushikubi, Y. Abiko, H. Matsumura, 2006 .

Effect of silodosin, a selective α(1A)-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction.

O. Yamaguchi, A. Yokoyama, K. Maruyama, 2015, European journal of pharmacology.

Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.

Kayo Nakamura, J. Nabekura, H. Ishibashi, 2015, European journal of pharmacology.

Electrophysiological effects of SD‐3212, a new antiarrhythmic agent with vasodilator action, on guinea‐pig ventricular cells

I. Kodama, J. Toyama, R. Suzuki, 1995, British journal of pharmacology.

Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

H. Kusama, Y. Yamazaki, K. Maruyama, 2009, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

Bladder selectivity of the novel β3-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat

H. Kusama, Y. Yamazaki, K. Maruyama, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of Ritobegron (KUC-7483), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function in Cynomolgus Monkey

H. Kusama, Y. Yamazaki, K. Maruyama, 2012, Journal of Pharmacology and Experimental Therapeutics.

Bladder selectivity of the novel β3-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat

H. Kusama, Y. Yamazaki, K. Maruyama, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Electrophysiological effects of Ro 22–9194, a new antiarrhythmic agent, on guinea‐pig ventricular cells

I. Kodama, J. Toyama, R. Suzuki, 1995, British journal of pharmacology.

Antianginal Effects of Ranolazine in Various Experimental Models of Angina

M. Akahane, K. Maruyama, H. Komatsu, 1999, Arzneimittelforschung.

Absence of exacerbation of myocardial stunning in anesthetized dogs treated with KAD-1229, a novel hypoglycemic agent.

K. Maruyama, T. Yamato, Atsutoshi Tsuji, 2001, European journal of pharmacology.